Search

Your search keyword '"Xanthines chemistry"' showing total 403 results

Search Constraints

Start Over You searched for: Descriptor "Xanthines chemistry" Remove constraint Descriptor: "Xanthines chemistry"
403 results on '"Xanthines chemistry"'

Search Results

1. Synthesis and Medicinal Applications of N-Heterocyclic Carbene Complexes Based on Caffeine and Other Xanthines.

2. Insights into the selectivity of polar stationary phases based on quantitative retention mechanism assessment in hydrophilic interaction chromatography.

3. Novel Insecticidal Butenolide-Containing Methylxanthine Derivatives: Synthesis, Crystal Structure, Biological Activity Evaluation, DFT Calculation and Molecular Docking.

4. Structure-Activity Relationship Studies in a Series of Xanthine Inhibitors of SLACK Potassium Channels.

5. 8-Bicycloalkyl-CPFPX derivatives as potent and selective tools for in vivo imaging of the A 1 adenosine receptor.

6. Nucleoside Phosphorylases make N7-xanthosine.

7. [Investigation of Mechanism of Creming-down Phenomenon and Development of High-order Functions Using Tea Catechins].

8. Synthesis and biological evaluation of xanthine derivatives with phenacyl group as tryptophan hydroxylase 1 (TPH1) inhibitors for obesity and fatty liver disease.

9. Towards a comprehensive understanding of RNA deamination: synthesis and properties of xanthosine-modified RNA.

10. Synthesis of xanthosine 2-phosphate diesters via phosphitylation of the carbonyl group.

11. Chemical and Skincare Property Characterization of the Main Cocoa Byproducts: Extraction Optimization by RSM Approach for Development of Sustainable Ingredients.

12. Synthesis, In Silico Prediction and In Vitro Evaluation of Antimicrobial Activity, DFT Calculation and Theoretical Investigation of Novel Xanthines and Uracil Containing Imidazolone Derivatives.

13. Estimation of the lipophilicity of purine-2,6-dione-based TRPA1 antagonists and PDE4/7 inhibitors with analgesic activity.

14. Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors.

15. Parvaxanthines D-F and Asponguanosines C and D, Racemic Natural Hybrids from the Insect Cyclopelta parva .

16. The role of spinal inhibitory neuroreceptors in the antihyperalgesic effect of warm water immersion therapy.

17. Unique Role of Caffeine Compared to Other Methylxanthines (Theobromine, Theophylline, Pentoxifylline, Propentofylline) in Regulation of AD Relevant Genes in Neuroblastoma SH-SY5Y Wild Type Cells.

18. Human TRPC5 structures reveal interaction of a xanthine-based TRPC1/4/5 inhibitor with a conserved lipid binding site.

19. Development and Evaluation of a Versatile Receptor-Ligand Binding Assay Using Cell Membrane Preparations Embedded in an Agarose Gel Matrix and Evaluation with the Human Adenosine A 1 Receptor.

20. Changes in the Composition of Methylxanthines, Polyphenols, and Volatiles and Sensory Profiles of Cocoa Beans from the Sul 1 Genotype Affected by Fermentation.

21. Protective Effect of Methylxanthine Fractions Isolated from Bancha Tea Leaves against Doxorubicin-Induced Cardio- and Nephrotoxicities in Rats.

22. Modified graphene-silica as a sorbent for in-tube solid-phase microextraction coupled to liquid chromatography-tandem mass spectrometry. Determination of xanthines in coffee beverages.

23. Excited-State Proton Transfer in 8-Azapurines I: A Kinetic Analysis of 8-Azaxanthine Fluorescence.

24. Bronchospasmolytic activity and adenosine receptor binding of some newer 1,3-dipropyl-8-phenyl substituted xanthine derivatives.

25. Bioactive Polyhydroxanthones from Penicillium purpurogenum .

26. Novel, Dual Target-Directed Annelated Xanthine Derivatives Acting on Adenosine Receptors and Monoamine Oxidase B.

27. Synthesis, radiolabelling and initial biological characterisation of 18 F-labelled xanthine derivatives for PET imaging of Eph receptors.

28. Racemic xanthine and dihydroxydopamine conjugates from Cyclopelta parva and their COX-2 inhibitory activity.

29. Extraction of methyl xanthines and their UHPLC-DAD determination in consumable beverages used in Eastern province of Saudi Arabia.

30. Sequential Xanthalation and O -Trifluoromethylation of Phenols: A Procedure for the Synthesis of Aryl Trifluoromethyl Ethers.

31. Revisiting the spectroscopy of xanthine derivatives: theobromine and theophylline.

32. Graphene Oxide: A Smart (Starting) Material for Natural Methylxanthines Adsorption and Detection.

33. Synthesis of new isoquinoline-base-oxadiazole derivatives as potent inhibitors of thymidine phosphorylase and molecular docking study.

34. Identifying the novel inhibitors of lysine-specific demethylase 1 (LSD1) combining pharmacophore-based and structure-based virtual screening.

35. Isolation, analysis and in vitro assessment of CYP3A4 inhibition by methylxanthines extracted from Pu-erh and Bancha tea leaves.

36. Structure-Activity Relationships, Pharmacokinetics, and Pharmacodynamics of the Kir6.2/SUR1-Specific Channel Opener VU0071063.

37. Diversity in Composition of Bioactive Compounds Among 26 Cocoa Genotypes.

38. Synthesis and biological evaluation of novel xanthine derivatives as potential apoptotic antitumor agents.

39. Exploring the structural determinants of novel xanthine derivatives as A 2B adenosine receptor antagonists: a computational study.

40. An Advanced In Silico Modelling of the Interaction between FSCPX, an Irreversible A 1 Adenosine Receptor Antagonist, and NBTI, a Nucleoside Transport Inhibitor, in the Guinea Pig Atrium.

41. Synthesis, biological evaluation and molecular modelling studies of 1,3,7,8-tetrasubstituted xanthines as potent and selective A 2A AR ligands with in vivo efficacy against animal model of Parkinson's disease.

42. Drug Delivery Systems: Study of Inclusion Complex Formation between Methylxanthines and Cyclodextrins and Their Thermodynamic and Transport Properties.

43. A 2B Adenosine Receptor Antagonists with Picomolar Potency.

44. Methylxanthine derivatives promote autophagy in gastric cancer cells targeting PTEN.

45. 1-Hydroxy-xanthine derivatives inhibit the human Caf1 nuclease and Caf1-containing nuclease complexes via Mg 2+ -dependent binding.

46. Theobromine and related methylxanthines as inhibitors of Primary Amine Oxidase.

47. Pharmacological potential of methylxanthines: Retrospective analysis and future expectations.

48. Pressurized liquid extraction of flavanols and alkaloids from cocoa bean shell using ethanol as solvent.

49. Determination of ligand efficiency indices in a group of 7H-purine-2,6-dione derivatives with psychotropic activity using micellar electrokinetic chromatography.

50. FSCPX, a Chemical Widely Used as an Irreversible A₁ Adenosine Receptor Antagonist, Modifies the Effect of NBTI, a Nucleoside Transport Inhibitor, by Reducing the Interstitial Adenosine Level in the Guinea Pig Atrium.

Catalog

Books, media, physical & digital resources